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Objective: Ovarian mature cystic teratomas with malignant transformation are rare, and squamous cell
carcinoma is the most common pathological entity. Among these malignant transformations, urothelial
cell carcinoma is rare.
Case Report: We report a woman presenting with a huge pelvic cystic mass, favoring a right ovarian
mature cystic teratoma with malignant transformation, based on magnetic resonance imaging, who was
successfully treated with surgery.
Conclusion: The ﬁnal pathology conﬁrmed concomitant malignant transformation of urothelial
carcinoma.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Mature cystic teratoma (MCT) is one of the common benign
ovarian tumors. The incidence of malignant transformation inMCTs
is 1e3%. Among these malignant transformations, squamous cell
carcinoma, adenocarcinoma, and carcinoid tumor account for most
malignant transformations [1]; however, the co-existence of uro-
thelial carcinoma within MCT is rare [2]. Here, we present the case
of a woman with an incidental ﬁnding of a urothelial carcinoma
arising from a large right ovarian MCT, who was successfully
treated by surgery.
Case Report
A 54-year-old nulliparous postmenopausal woman presented
with abdominal distension and vaginal spotting. The initial pelvic
examination disclosed a huge, soft mass in the pelvic cavity.
Transabdominal ultrasonography revealed an
18 cm  12 cm  20 cm cystic mass with a smooth surface and a
small fatty component within the right ovary. The tumor markers
were as follows: carcinoembryonic antigen, 5.41 ng/mL (reference
range < 5.0 ng/mL); carbohydrate antigen (CA)-125, 45.35 IU/mLand Gynecology, Kaohsiung
oad, Kaohsiung, 807, Taiwan.
bstetrics & Gynecology. Published(reference range < 36.3 IU/mL); and CA 19-9, 928.41 IU/mL (refer-
ence range < 37.0 IU/mL). The other laboratory testing revealed no
abnormalities. Pelvic magnetic resonance (MR) showed a
19 cm  12 cm  20 cm, lobulated cystic-solid mass with a fatty
component in the right ovary (Figure 1A). The tumor had a small
solid component inside the cystic lobulated component, and an
enhancing papillary mural nodule projection into the cystic lumen
(Figure 1B). The soft mural nodule was 4 cm in size and there was
an obtuse angle between the soft component and the inner wall,
favoring malignant transformation. A uterine myoma and mild
ascites with borderline enlarged lymph nodes in the left internal
iliac area were also noted. Colonoscopy and cystoscopy were
normal.
A midline laparotomy was performed, with a provisional diag-
nosis of malignant transformation of MCT based on the large size,
high serum CA19-9 level, and the speciﬁc ﬁnding of small solid
components on pelvic MR. At the time of surgery, scant clear, yel-
low ascites was noted in the pelvis. A huge smooth-surfaced cystic
tumor was palpated and ~2.3 L of clear, brown ﬂuid was evacuated.
The left ovary and uterus were grossly normal. Initially, a right
salpingo-oophorectomy was performed. Grossly, a solid lesion was
identiﬁed on the inner surface of the cyst, which measured
4.0 cm  3.0 cm  1.4 cm in size (Figure 2A) and the excised tumor
was sent for frozen evaluation, which revealed a cystic teratoma
with possible malignant transformation. Debulking surgery was
then performed without incident.by Elsevier Taiwan LLC. All rights reserved.
Figure 1. (A) Sagittal enhanced T1-weighted magnetic resonance image shows a huge cystic mass, measuring 19 cm  12 cm  20 cm, in the right ovary. A fatty lesion was found
within the cyst (black arrow). (B) Enhanced papillary mural nodules (arrowhead), measuring 4 cm projection into the cystic lumen, made an obtuse angle (asterisk) between the soft
component and the inner wall.
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sisting of mature skin appendages lined by squamous, respiratory,
and urothelial epithelium (Figure 2B). Complex close-packed,
irregular nests and papillary structure of urothelial cells inﬁl-
trating the stromawere noted in the solid mass area. The urothelial
cells showed well-differentiated cytological features and the adja-
cent area showed benign urothelial epithelium. No extra-ovarian
extension was identiﬁed. The ﬁnal pathology report conﬁrmed
the co-existence of urothelial carcinoma from the ovarian MCT.
The patient had an uneventful postoperative course and was
discharged 4 days later without sequelae. Subsequent 18-
ﬂuorodeoxyglucose positron emission tomography/computed to-
mography (18-FDG PET/CT) did not show distant metastasis or local
recurrence 8 months later.
Discussion
MCT is one of the most common ovarian tumors and accounts
for 10e25% of ovarian tumors [1]. Malignant transformation, a rare
pathological entity, occurs in 1e2% of MCTs and is rarely recognized
preoperatively [1e3]. For patients with malignant transformation,
squamous cell carcinoma is the most common malignancy arising
fromMCT, and accounts for 80% of all cases [4]. Other malignancies,
such as adenocarcinomas, sarcomas, ormalignantmelanomas, have
been reported [2,4]; however, urothelial carcinoma arising fromFigure 2. (A) Gross photograph of right ovarian tumor. A mural solid tissue mass (white a
packed, irregular nests and papillary structure of urothelial cells inﬁltrating the stroma (b
tures. The adjacent area shows benign urothelial epithelium (black arrow; hematoxylin andMCT is rare. Only ﬁve cases of urothelial carcinoma arising from
MCT have been reported, including the patient reported here. An
extensive review of the literature of urothelial carcinomamalignant
transformation is presented in Table 1 [1,5e7]. The mean age of the
ﬁve cases was 53 years. Only two of these were postmenopausal
and the other twowere premenopausal; this is not compatiblewith
the previously published data [2,3,6]. Mostly, these tumor masses
were > 10 cm in size at the time of diagnosis and malignant
transformation of urothelial carcinoma was found in the early
stages. All of these patients were treated primarily by surgery,
including salpingo-oophorectomy. Only one patient underwent
adjuvant chemotherapy, possibly for advanced stage disease [5].
The common clinical manifestations of malignant trans-
formation of MCT include abdominal mass, abdominal pain,
weight loss, abdominal distension, vagina bleeding, and urinary
frequency [3,4,6]. Although malignant transformation can occur
at any age, it seems that most patients have this condition during
the postmenopausal period. The other risk factors of malignant
transformation include older age (> 45 years), concomitant
larger tumor size (> 9.9 cm), and elevated serum tumor markers
(CA125, CA199, carcinoembryonic antigen, and squamous cell
carcinoma antigen e SCC) [2,3,6]. No speciﬁc tumor marker is
used to detect or screen concomitant malignant transformation
of MCT, especially urothelial carcinoma, but CA125 and CA199
may be elevated in some cases (Table 1) [5].rrow) was noted inside the cystic tumor without serosa invasion. (B) Complex close-
lack arrowhead) are noted. The urothelial cell shows moderate grade cytological fea-
eosin, 10).
Table 1
Reported cases of urothelial carcinoma arising from ovary cystic teratoma.
Study Age
(y)
Menopause Symptoms at
diagnosis
Tumor size
(cm)
Right/left Tumor
marker
elevated
FIGO
stage
Primary surgery Further
treatment
Follow-up
1 Lee et al [5], 1999 67 Post voiding difﬁculty
lower abdominal
pain
14  7  5 left CA-125
CA 19-9
1C ATH þ BSO þ omentectomy Chemotherapy:
carboplatin
etoposide
NED
5 mo
2 Kido et al [1], 1999 48 NA NA NA a NA NA 1C NA NA NDA
3 Rayyan et al [6], 2009 45 Pre Pain
bleeding
8 Left NA 1A LSO Surgical staging NED
>5 y
4 Lee & Lee [7], 2010 52 Pre Abdominal mass 22  19  5 Right NA 1A RSO NA NED
15 mo
5 Present case 54 Post Abdominal mass 20  13  21 Right CA-125
CA 19-9
1A Debulking (ATH þ
BSO þ omentectomy þ BPLA)
None NED
8 mo
ATH ¼ abdominal total hysterectomy; BPLA ¼ bilateral pelvic lymphadenectomy; BSO ¼ bilateral salpingo-oophorectomy; DOD ¼ died of disease; FIGO¼ International
Federation of Obstetrics and Gynecology; LSO¼ left salpingo-oophorectomy; NA¼ not available; NDA¼ no data available; NED¼ no evidence of disease; RSO¼ right salpingo-
oophorectomy.
a The authors did not mention the size of this tumor, but they described that the ﬁve tumors ranged from 10 cm  10 cm to 14 cm  32 cm.
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formation is difﬁcult to identify before surgery. MR is useful in the
detection of occult malignancy arising from MCTs [1,3]. The appear-
ance of MCTs can vary, but the surface of benign MCTs is always
smooth. A soft tissue protuberance into the cystic lumen, known as
Rokitanskynodule, is common inMCTs. TheRokitanskynodulenever
shows a transmural growth pattern, favoring malignant trans-
formation [3]. MCT with malignant transformation is characterized
by the speciﬁc MR ﬁndings: > 9.9 cm; presence of enhancing soft
tissue components; obtuse angle between the soft tissue compo-
nents and the inner cyst wall; transmural or extracapsular tumor
growth with extension into adjacent structures; or disseminated
metastasis [3]. It is reported that malignant transformation tends to
have solid components inside the tumor thatmay exhibit transmural
extension with direct invasion of neighboring organs. Moreover, 18-
FDG PET/CT has been used for the initial diagnosis and further stag-
ing when malignant transformation is highly suspected [3,8].
Although we applied an 18-FDG PET/CT survey for this patient
postoperatively, it still had its clinical signiﬁcance fordeﬁnite staging.
In conclusion, urothelial carcinoma arising fromMCT is rare. For
those patients with larger size, transmural-enhancing soft tissue
components inside the teratoma, > 45 years of age, or elevated
tumor markers, the possibility of malignant transformation should
not be omitted. Moreover, an adjunct PET/CT might be considered
for preoperative staging if malignant transformation is suspected.Conﬂicts of interest
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